Rapport Therapeutics, Inc.
RAPP
$11.43
$0.050.44%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -4.80% | -4.60% | 73.95% | 31.03% | -- |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -66.67% | -30.77% | -75.83% | 258.60% | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -3.56% | 35.67% | 2,973.33% | -94.46% | -- |
| Total Current Assets | -4.95% | -4.32% | 71.42% | 31.72% | -- |
|
|
|||||
| Total Current Assets | -4.95% | -4.32% | 71.42% | 31.72% | -- |
| Net Property, Plant & Equipment | -0.90% | -4.33% | -4.46% | 37.20% | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -15.34% | 0.00% | -90.88% | 276.23% | -- |
| Total Assets | -4.90% | -4.32% | 67.77% | 32.73% | -- |
|
|
|||||
| Total Accounts Payable | 47.69% | -29.44% | 29.49% | -42.13% | -- |
| Total Accrued Expenses | 20.17% | -8.36% | -28.82% | 37.65% | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.36% | 2.42% | 2.48% | 2.39% | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 23.50% | -12.30% | -18.11% | 12.29% | -- |
|
|
|||||
| Total Current Liabilities | 23.50% | -12.30% | -18.11% | 12.29% | -- |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -20.62% | -16.65% | -13.94% | -12.06% | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 18.38% | -12.83% | -17.62% | -22.76% | -- |
|
|
|||||
| Common Stock & APIC | 0.75% | 0.75% | 1,378.30% | 44.62% | -- |
| Retained Earnings | -19.26% | -20.34% | -26.61% | -49.89% | -- |
| Treasury Stock & Other | -230.50% | 318.58% | -14.38% | -4,100.00% | -- |
| Total Common Equity | -5.47% | -4.09% | 950.01% | -54.61% | -- |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | 40.92% | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | 40.92% | -- |
|
|
|||||
| Total Common Equity | -5.47% | -4.09% | 950.01% | -54.61% | -- |
| Total Preferred Equity | -- | -- | -- | 40.92% | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -5.47% | -4.09% | 72.67% | 38.43% | -- |
|
|
|||||